We are live on
!
Find out more
ESPR
Esperion Therapeutics
ESPR
ESPR
Delisted
ESPR was delisted on the 10th of July, 2026.
151 hedge funds and large institutions have $1.38B invested in Esperion Therapeutics in 2015 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 70 increasing their positions, 26 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
169% more repeat investments, than reductions
Existing positions increased: 70 | Existing positions reduced: 26
125% more call options, than puts
Call options by funds: $139M | Put options by funds: $61.6M
29% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 35
7% more funds holding
Funds holding: 141 → 151 (+10)
0% more capital invested
Capital invested by funds: $1.38B → $1.38B (+$5.87M)
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
151
Holders Change
+10
Holders Change %
+7.09%
% of All Funds
4.07%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.08%
New
45
Increased
70
Reduced
26
Closed
35
Calls
$139M
Puts
$61.6M
Net Calls
+$77.3M
Net Calls Change
+$74.3M
Top Buyers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$123M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$30.5M |
| 3 |
CCI
Columbus Circle Investors
|
+$28.8M |
| 4 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$21.7M |
| 5 |
SAM
Senzar Asset Management
New York
|
+$15.1M |
Top Sellers
| 1 |
VAM
Visium Asset Management
New York
|
-$60M |
| 2 |
AC
Aisling Capital
New York
|
-$40.9M |
| 3 |
ICAP
Independence Capital Asset Partners
Denver,
Colorado
|
-$14.7M |
| 4 |
Marshall Wace
London,
United Kingdom
|
-$10.2M |
| 5 |
JP Morgan Chase
New York
|
-$9.97M |
